Astraea
YC X26San Francisco, US · Founded 2026 · Delaware corporation · 2 employees · Hiring · 6 known investors
Find your way into Astraea
759 people in our graph share verified history with the Astraea team — schools, employers, funds. One of them is your warm intro.
Paul Kwanunlockedknows Joshua Wang · together at Stanford University (overlapped)
knows the team · via Stanford University
×10knows the team · via Y Combinator
Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.
AI & Machine LearningBiotechEnterprise SoftwareHealthtechMedical DevicesUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (X26)
Astraea was founded in 2026 by Joshua Wang and Sanmay Sarada.
JW
Joshua Wangin𝕏FounderJoshua Wang left Stanford where he studied computer science and mathematics. He has competed in mathematics olympiads (USAMO) and competitive programming (USACO Platinum), and interned at Salient developing enterprise systems.
SS
Sanmay SaradainFounderSanmay Sarada is a data engineer who previously worked at Baylor College of Medicine and has published research in fetal medicine. He studied computer science and biology at Stanford University.
BR
Brendan RichardsonNamed on SEC filing
DB
Daniel BaileyNamed on SEC filing
Investors · 6
Also in the syndicate · 4
Carbon Drawdown CollectiveleadCAV AngelsTydall Investment PartnersUniversity of Virginia (UVA) Seed Fund
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 5 rounds · 2017–2022
▶$6.4MraisedJul 2022 · 15 investors · Other TechnologyRule 506(b)
▶$6.4MraisedJul 2022 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BaileyExecutive Officer, Director
- Thomas BartonDirector
- Walter R. Bashaw IIDirector
- Eric T. YonkeDirector
- Geoff WoolleyDirector
- Brendan RichardsonExecutive Officer, Director
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedSep 2020 · 9 investors · Other TechnologyRule 506(b)
▶$3.7MraisedSep 2020 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jon WattsDirector
- Thomas BartonDirector
- Brendan RichardsonExecutive Officer, Director
- Eric T. YonkeDirector
- Geoff WoolleyDirector
- Daniel BaileyExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $3.7M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.6MraisedSep 2020 · 10 investors · Other TechnologyRule 506(b)
▶$3.6MraisedSep 2020 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Walter R. BashawDirector
- Brendan RichardsonExecutive Officer, Director
- Geoff WooleyDirector
- Eric T. YonkeDirector
- Jon WattsDirector
- Tom BartonDirector
- Daniel BaileyDirector
- Offering amount
- $4.7M
- Amount sold
- $3.6M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$465KraisedJul 2018 · 7 investors · Other TechnologyRule 506(b)
▶$465KraisedJul 2018 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff WooleyDirector
- Brendan RichardsonExecutive Officer, Director
- Walter R. BashawDirector
- Eric T. YonkeDirector
- Daniel BaileyDirector
- Offering amount
- $600K
- Amount sold
- $465K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.2MraisedSep 2017 · 6 investors · Other TechnologyRule 506(b)
▶$3.2MraisedSep 2017 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brendan RichardsonExecutive Officer, Director
- Daniel BaileyDirector
- Offering amount
- $3.6M
- Amount sold
- $3.2M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Astraea do?
- Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.
- Who founded Astraea?
- Astraea was founded by Joshua Wang, Sanmay Sarada in 2026.
- Who are Astraea's investors?
- Astraea's investors include Y Combinator, Aligned Climate Capital.
- How much funding has Astraea raised?
- Astraea has disclosed $17.3M raised across 5 rounds.
- Where is Astraea headquartered?
- Astraea is headquartered in San Francisco, US.